pubmed.ncbi.nlm.nih.gov

Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 - PubMed

Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53

N C Reich et al. Mol Cell Biol. 1983 Dec.

Abstract

The steady-state levels of p53 protein and p53 mRNA in transformed and nontransformed cells were examined to elucidate the mechanisms controlling expression of p53. mRNA levels were determined by Northern blot hybridization analysis, employing a p53-specific cDNA clone (M. Oren and A.J. Levine, Proc. Natl. Acad. Sci. U.S.A. 80:56-59, 1983), and protein levels were determined by the Western blotting technique. Analysis of p53 mRNA revealed a single polyadenylated mRNA species migrating at ca. 18S. Levels of p53 mRNA in simian virus 40-transformed cell line (SVT2) and in an homologous nontransformed cell line (3T3) were equivalent, although the steady-state levels of p53 protein were 25- to 100-fold higher in the SVT2 cells than in the 3T3 cells. A study with a non-virus-transformed cell system revealed a different result. Embryonal carcinoma cells (F9) were found to have nearly 20-fold higher levels of p53 mRNA in comparison with differentiated benign progeny cells. In this system the difference in p53 mRNA levels corresponded to the difference in p53 protein levels. Pulse-chase experiments were performed to study the half-life of p53 protein in these four types of cells. The turnover of p53 protein occurred with biphasic kinetics. In addition, it was found that protein synthesis inhibitors placed in the medium during the chase period prevented the turnover of p53 protein in transformed cells, but not in nontransformed (3T3) cells. These results provide evidence that the regulation of p53 expression in cells can occur at the level of p53 mRNA abundancy or p53 protein stability depending upon the experimental system under study, and that a regulated degradation process controls the turnover of p53 protein.

PubMed Disclaimer

Cited by

Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.
Halevy O, Hall A, Oren M. Halevy O, et al. Mol Cell Biol. 1989 Aug;9(8):3385-92. doi: 10.1128/mcb.9.8.3385-3392.1989. Mol Cell Biol. 1989. PMID: 2529426 Free PMC article.
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.
Halbert CL, Demers GW, Galloway DA. Halbert CL, et al. J Virol. 1991 Jan;65(1):473-8. doi: 10.1128/JVI.65.1.473-478.1991. J Virol. 1991. PMID: 1845902 Free PMC article.
Identification and characterization of the protein encoded by the human c-myb proto-oncogene.
Klempnauer KH, Bonifer C, Sippel AE. Klempnauer KH, et al. EMBO J. 1986 Aug;5(8):1903-11. doi: 10.1002/j.1460-2075.1986.tb04443.x. EMBO J. 1986. PMID: 3530745 Free PMC article.
Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation.
Rovinski B, Munroe D, Peacock J, Mowat M, Bernstein A, Benchimol S. Rovinski B, et al. Mol Cell Biol. 1987 Feb;7(2):847-53. doi: 10.1128/mcb.7.2.847-853.1987. Mol Cell Biol. 1987. PMID: 3547084 Free PMC article.
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay CA. Finlay CA. Mol Cell Biol. 1993 Jan;13(1):301-6. doi: 10.1128/mcb.13.1.301-306.1993. Mol Cell Biol. 1993. PMID: 8417333 Free PMC article.

References

1. J Cell Physiol. 1968 Oct;72(2):141-8 - PubMed
1. Biochemistry. 1977 Oct 18;16(21):4743-51 - PubMed
1. Nature. 1979 Mar 15;278(5701):261-3 - PubMed
1. Proc Natl Acad Sci U S A. 1979 May;76(5):2420-4 - PubMed
1. Cell. 1979 May;17(1):43-52 - PubMed

Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 - PubMed